These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Evaluation of methadone dispensing in Belgium--study synopsis]. Ledoux Y J Pharm Belg; 2004; 59(3):69-79. PubMed ID: 15553322 [No Abstract] [Full Text] [Related]
26. Clinical applications of methadone. Wheeler WL; Dickerson ED Am J Hosp Palliat Care; 2000; 17(3):196-203. PubMed ID: 11886072 [No Abstract] [Full Text] [Related]
27. Very-high-dose methadone with minimal toxicity and inadequate pain control in a hospice patient with cancer. Latuga NM; Wahler RG J Pain Palliat Care Pharmacother; 2013 Jun; 27(2):143-9. PubMed ID: 23646910 [TBL] [Abstract][Full Text] [Related]
29. The successful use of parenteral methadone in a patient with a prolonged QTc interval. Sekine R; Obbens EA; Coyle N; Inturrisi CE J Pain Symptom Manage; 2007 Nov; 34(5):566-9. PubMed ID: 17616330 [TBL] [Abstract][Full Text] [Related]
30. Intraoperative Methadone: New Use for an Old Drug. Wolfe RC J Perianesth Nurs; 2020 Apr; 35(2):219-221. PubMed ID: 32247434 [No Abstract] [Full Text] [Related]
31. Exceptionally high narcotic analgesic requirements in a terminally ill cancer patient. Lo SL; Coleman RR Clin Pharm; 1986 Oct; 5(10):828-32. PubMed ID: 2430752 [No Abstract] [Full Text] [Related]
32. Methadone for cancer pain: what have we learned from clinical studies? Soares LG Am J Hosp Palliat Care; 2005; 22(3):223-7. PubMed ID: 15909785 [TBL] [Abstract][Full Text] [Related]
33. Opioid-sparing effect of diclofenac in cancer pain. Mercadante S; Sapio M; Caligara M; Serretta R; Dardanoni G; Barresi L J Pain Symptom Manage; 1997 Jul; 14(1):15-20. PubMed ID: 9223838 [TBL] [Abstract][Full Text] [Related]
34. Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran. Farnia M; Ebrahimi B; Shams A; Zamani S Int J Drug Policy; 2010 Sep; 21(5):422-4. PubMed ID: 20413287 [TBL] [Abstract][Full Text] [Related]
35. Rotation to methadone after opioid dose escalation: How should individualization of dosing occur? Zimmermann C; Seccareccia D; Booth CM; Cottrell W J Pain Palliat Care Pharmacother; 2005; 19(2):25-31. PubMed ID: 16061458 [TBL] [Abstract][Full Text] [Related]
36. A six-year evaluation of methadone prescribing practices at a substance misuse treatment centre in the UK. Newman RG J Clin Pharm Ther; 2007 Jun; 32(3):325; author reply 325-6. PubMed ID: 17489886 [No Abstract] [Full Text] [Related]
37. Treatment of acute pain in opioid tolerant patients. Bean HK; Gannon R Conn Med; 2010 Mar; 74(3):143-8. PubMed ID: 20391820 [No Abstract] [Full Text] [Related]
38. Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment. Madden A; Lea T; Bath N; Winstock AR Drug Alcohol Rev; 2008 Nov; 27(6):671-8. PubMed ID: 19378450 [TBL] [Abstract][Full Text] [Related]
39. Tapering and discontinuation of methadone for chronic pain. Breivik H J Pain Palliat Care Pharmacother; 2015 Jun; 29(2):185-6. PubMed ID: 26095495 [TBL] [Abstract][Full Text] [Related]
40. Successful prophylactic treatment of chronic cluster headache with low-dose levomethadone. Sprenger T; Seifert CL; Miederer M; Valet M; Tölle TR J Neurol; 2008 Nov; 255(11):1832-3. PubMed ID: 19156493 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]